Department of Chemistry, Faculty of Women for Arts, Science and Education, Ain Shams University, Heliopolis, Cairo 11757, Egypt.
Department of Chemistry, Faculty of Science, Beni-Suef University, Beni-Suef 62514, Egypt.
Med Chem. 2020;16(6):750-760. doi: 10.2174/1573406415666190620144404.
Pyrazole and its derivatives are known to exhibit significant biological and pharmacological activities such as anticancer, anti-inflammatory, antioxidant, antibacterial, analgesic, antiviral, antimicrobial, antifungal, anti-glycemic, antiamoebic, and antidepressive. Considering the immense biological properties, pyrazole is one of the most widely studied nitrogen- containing heterocyclic nuclei. Fused pyrazole derivatives are composed of the pyrazole nucleus attached to other heterocyclic moieties.
The objective of this article is the synthesis of some new pyrazolo[1,5-a]pyrimidine and pyrazolo[5,1-c]1,2,4-triazine derivatives with potential anticancer and antimicrobial activities.
The in vitro growth inhibitory rates (%) and inhibitory growth activity (as measured by IC50) of the newly synthesized compounds were determined against the MCF-7 human breast carcinoma cell line in comparison with the well-known anticancer drug doxorubicin as the standard, using the MTT viability assay. The data generated were used to plot a dose-response curve from which the concentration (μM) of tested compounds required to kill 50% of the cell population (IC50) was determined. Cytotoxic activity was expressed as the mean IC50 of three independent experiments. The difference between inhibitory activities of all compounds with different concentrations was statistically significant p < 0.001. All compounds were structurally characterized by different spectroscopic techniques EI-MS, 1H-NMR, and 13C-NMR, and evaluated for their anticancer and antimicrobial activities (antibacterial and antifungal).
Several pyrazolo[1,5-a]pyrimidine derivatives were synthesized from the reaction of 2-(4- (5-amino-1H-pyrazol-3-yl)phenyl)-1H-indene-1,3(2H)-dione with the appropriate active methylene compounds in boiling ethanol. Also, pyrazolo[5,1-c]triazines were obtained through the reaction of 2-(4-(5-(chlorodiazenyl)-1H-pyrazol-3-yl)phenyl)-1H-indene-1,3(2H)-dione with various active methylene compounds in ethanol containing sodium acetate at 0-5 oC. The structures of the newly synthesized compounds were elucidated on the basis of elemental analysis, spectral data, and alternative synthetic routes whenever possible. The newly synthesized compounds were evaluated for their antitumor activity against a breast cancer cell line (MCF-7) and a human colon cancer cell line (HCT-116). The results revealed that the tested compounds showed high variation in the inhibitory growth rates and activities against the tested tumor cell lines. All newly synthesized compounds screen towards microorganisms e.g. Gram-negative bacteria, Gram-positive bacteria, and Fungi.
2-(4-(5-Amino-1H-pyrazol-3-yl)phenyl)isoindoline-1,3-dione proved to be a useful precursor for the synthesis of various pyrazolo[1,5-a]pyrimidine and pyrazolo[5,1-c]-1,2,4- triazines. The structures of the newly synthesized compounds were confirmed by spectral data and elemental analyses. The newly synthesized compounds were tested in vitro against the MCF-7, HCT-116 human cancer cell line and compared with doxorubicin as the standard, using the MTT viability assay. Most of the tested compounds were found to have moderate to high anticancer activity.
吡唑及其衍生物具有显著的生物和药理活性,如抗癌、抗炎、抗氧化、抗菌、镇痛、抗病毒、抗菌、抗真菌、降血糖、抗阿米巴、抗抑郁等。考虑到其巨大的生物学特性,吡唑是研究最多的含氮杂环核之一。稠合吡唑衍生物由连接到其他杂环部分的吡唑核组成。
本文的目的是合成一些具有潜在抗癌和抗菌活性的新吡唑并[1,5-a]嘧啶和吡唑并[5,1-c]1,2,4-三嗪衍生物。
采用 MTT 法测定新合成化合物对 MCF-7 人乳腺癌细胞系的体外生长抑制率(%)和抑制生长活性(以 IC50 表示),并与著名的抗癌药物阿霉素作为标准进行比较。用生成的数据绘制剂量-反应曲线,从该曲线中确定杀死 50%细胞群体所需的测试化合物的浓度(μM)(IC50)。细胞毒性活性表示为三个独立实验的平均 IC50。不同浓度的所有化合物的抑制活性差异具有统计学意义(p < 0.001)。所有化合物均通过不同的光谱技术 EI-MS、1H-NMR 和 13C-NMR 进行结构表征,并评估其抗癌和抗菌活性(抗菌和抗真菌)。
通过 2-(4-(5-氨基-1H-吡唑-3-基)苯基)-1H-茚-1,3(2H)-二酮与适当的活性亚甲基化合物在沸腾乙醇中的反应合成了几种吡唑并[1,5-a]嘧啶衍生物。此外,通过 2-(4-(5-(氯二氮烯基)-1H-吡唑-3-基)苯基)-1H-茚-1,3(2H)-二酮与各种活性亚甲基化合物在含有醋酸钠的乙醇中的反应得到吡唑并[5,1-c]三嗪。新合成化合物的结构基于元素分析、光谱数据和替代合成路线进行阐明,只要有可能。新合成的化合物被评估对乳腺癌细胞系(MCF-7)和人结肠癌细胞系(HCT-116)的抗肿瘤活性。结果表明,测试化合物对测试的肿瘤细胞系的生长抑制率和活性表现出高度的变化。所有新合成的化合物均对微生物具有筛选作用,例如革兰氏阴性菌、革兰氏阳性菌和真菌。
2-(4-(5-氨基-1H-吡唑-3-基)苯基)异吲哚啉-1,3-二酮被证明是合成各种吡唑并[1,5-a]嘧啶和吡唑并[5,1-c]-1,2,4-三嗪的有用前体。新合成化合物的结构通过光谱数据和元素分析得到证实。新合成的化合物在体外对 MCF-7、HCT-116 人癌细胞系进行了测试,并与阿霉素作为标准进行了比较,采用 MTT 活力测定法。大多数测试化合物被发现具有中度至高度的抗癌活性。